Romidepsin (FK228) in a Mouse Model of Lipopolysaccharide-Induced Acute Kidney Injury is Associated with Down-Regulation of the CYP2E1 Gene

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2020 Jan 19

PMID 31954012

Citations 6

Authors

Shulin Cheng

Tao Wu

Yugen Li

Jing Huang

Tao Cai

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Romidepsin (FK228) or depsipeptide, is a selective inhibitor of histone deacetylase 1 (HDAC1) and HDAC2. This study aimed to investigate the effects and molecular mechanisms of romidepsin (FK228) in a mouse model of acute kidney injury (AKI) induced by lipopolysaccharide (LPS). MATERIAL AND METHODS The mouse model of AKI was developed by intraperitoneal injection of LPS. The mice were also treated intraperitoneally with romidepsin (FK228) six hours following injection of LPS. Markers of renal injury were measured, including blood urea nitrogen (BUN), serum creatinine (SCR), and serum cystatin C (Cys C) were measured. Histology and transmission electron microscopy were performed to evaluate tissue injury further. Levels of HDACs were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. Co-immunoprecipitation (Co-IP) and chromatin immunoprecipitation (ChIP) assays were used to investigate the regulation of CYP2E1 expression. RESULTS Treatment with romidepsin (FK228) significantly reduced the levels of BUN, SCR, and Cys C induced by LPS. Histology of the mouse kidneys showed that treatment with romidepsin (FK228) reduced the degree of renal injury. CYP2E1 significantly reduced following treatment with romidepsin (FK228) in the mouse model of AKI. Also, acetylation of H3 was upregulated following treatment with romidepsin (FK228), and binding of hepatocyte nuclear factor-1 alpha (HNF-1a) on the CYP2E1 promoter was significantly increased. CONCLUSIONS In a mouse model of LPS-induced AKI, treatment with romidepsin (FK228) downregulated the expression of CYP2E1 by inhibiting the binding if HNF-1a with the CYP2E1 promoter to reduce renal injury.

Citing Articles

Comparative study of cytochrome P450 expression in the kidneys of Lepus yarkandensis and Oryctolagus cuniculus.

Zhang J, Li Y, Shao D, Chao B, Liu G Sci Rep. 2025; 15(1):6954.

PMID: 40011673 PMC: 11865575. DOI: 10.1038/s41598-025-91603-x.

EP300-mediated H3 acetylation elevates MTHFD2 expression to reduce mitochondrial dysfunction in lipopolysaccharide-induced tubular epithelial cells.

Hu W Ren Fail. 2024; 46(2):2369342.

PMID: 39230047 PMC: 11376309. DOI: 10.1080/0886022X.2024.2369342.

Histone Modifications in Acute Kidney Injury.

Wang J, Shen F, Liu F, Zhuang S Kidney Dis (Basel). 2023; 8(6):466-477.

PMID: 36590679 PMC: 9798838. DOI: 10.1159/000527799.

Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.

Kumar S, Singla B, Singh A, Thomas-Gooch S, Zhi K, Singh U Cells. 2022; 11(17).

PMID: 36078027 PMC: 9454765. DOI: 10.3390/cells11172620.

Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10.

Jiang W, Block M, Boosani C PLoS One. 2022; 17(2):e0263190.

PMID: 35143520 PMC: 8830685. DOI: 10.1371/journal.pone.0263190.

References

Stoyanoff T, Rodriguez J, Todaro J, Melana Colavita J, Torres A, Aguirre M . Erythropoietin attenuates LPS-induced microvascular damage in a murine model of septic acute kidney injury. Biomed Pharmacother. 2018; 107:1046-1055. DOI: 10.1016/j.biopha.2018.08.087. View

Damaskos C, Garmpis N, Karatzas T, Nikolidakis L, Kostakis I, Garmpi A . Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. Anticancer Res. 2015; 35(6):3129-35. View

Xu X, Nie S, Liu Z, Chen C, Xu G, Zha Y . Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults. Clin J Am Soc Nephrol. 2015; 10(9):1510-8. PMC: 4559507. DOI: 10.2215/CJN.02140215. View

Dennis J, Witting P . Protective Role for Antioxidants in Acute Kidney Disease. Nutrients. 2017; 9(7). PMC: 5537833. DOI: 10.3390/nu9070718. View

Furumai R, Matsuyama A, Kobashi N, Lee K, Nishiyama M, Nakajima H . FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 2002; 62(17):4916-21. View

Winckelmann A, Barton K, Hiener B, Schlub T, Shao W, Rasmussen T . Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS. 2017; 31(6):771-779. PMC: 5345886. DOI: 10.1097/QAD.0000000000001400. View

Xia J, Zhou Y, Ji H, Wang Y, Wu Q, Bao J . Loss of histone deacetylases 1 and 2 in hepatocytes impairs murine liver regeneration through Ki67 depletion. Hepatology. 2013; 58(6):2089-98. DOI: 10.1002/hep.26542. View

Zhou H, Cai Y, Liu D, Li M, Sha Y, Zhang W . Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21 and p19 upregulation in hepatocellular carcinoma. Cell Prolif. 2018; 51(3):e12447. PMC: 6528930. DOI: 10.1111/cpr.12447. View

Groll N, Petrikat T, Vetter S, Colnot S, Weiss F, Poetz O . Coordinate regulation of Cyp2e1 by β-catenin- and hepatocyte nuclear factor 1α-dependent signaling. Toxicology. 2016; 350-352:40-8. DOI: 10.1016/j.tox.2016.05.004. View

10.

Tang J, Yan Y, Zhao T, Bayliss G, Yan H, Zhuang S . Class I histone deacetylase activity is required for proliferation of renal epithelial cells. Am J Physiol Renal Physiol. 2013; 305(3):F244-54. PMC: 3742866. DOI: 10.1152/ajprenal.00126.2013. View

11.

Van Beneden K, Geers C, Pauwels M, Mannaerts I, Verbeelen D, van Grunsven L . Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol. 2011; 22(10):1863-75. PMC: 3279948. DOI: 10.1681/ASN.2010111196. View

12.

Liu T, Tang L, Tang H, Pu J, Gong S, Fang D . Zika Virus Infection Induces Acute Kidney Injury Through Activating NLRP3 Inflammasome Via Suppressing Bcl-2. Front Immunol. 2019; 10:1925. PMC: 6702322. DOI: 10.3389/fimmu.2019.01925. View

13.

Molitoris B . Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest. 2014; 124(6):2355-63. PMC: 4089444. DOI: 10.1172/JCI72269. View

14.

Gaillard S, Zahurak M, Sharma A, Durham J, Reiss K, Sartorius-Mergenthaler S . A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors. Cancer. 2019; 125(16):2837-2845. PMC: 6663621. DOI: 10.1002/cncr.32138. View

15.

Islam M, Miao L, Yu H, Han Z, Sun H . Ethanol Extract of Attenuates LPS-Induced Acute Kidney Injury in Mice via Regulating Inflammation and Oxidative Stress. Nutrients. 2019; 11(6). PMC: 6627762. DOI: 10.3390/nu11061412. View

16.

Gong P, Cederbaum A . Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology. 2005; 43(1):144-53. DOI: 10.1002/hep.21004. View

17.

Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon J, van der Lee R . JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2017; 46(D1):D260-D266. PMC: 5753243. DOI: 10.1093/nar/gkx1126. View

18.

Cheng P, Wang M, Morgan E . Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J Pharmacol Exp Ther. 2003; 307(3):1205-12. DOI: 10.1124/jpet.103.057174. View

19.

Matsunaga N, Ikeda M, Takiguchi T, Koyanagi S, Ohdo S . The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver. Hepatology. 2008; 48(1):240-51. DOI: 10.1002/hep.22304. View

20.

Cleophas M, Crisan T, Kluck V, Hoogerbrugge N, Netea-Maier R, Dinarello C . Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Res Ther. 2019; 21(1):50. PMC: 6366029. DOI: 10.1186/s13075-019-1834-x. View